The Global Antifungal Susceptibility Epidemiology of Trichophyton indotineae Indicating Voriconazole as an Alternative Therapy for Recalcitrant Dermatophytosis. [PDF]
Song G +5 more
europepmc +1 more source
Preparation and Optimization of Voriconazole Gel 0.25% for Topical Delivery in Terbinafine Resistance Dermatophytosis: In Vitro and Pilot Animal Study. [PDF]
Nasrollahi SA +9 more
europepmc +1 more source
Mental Health and Quality of Life in Chronic and Recurrent vs First-Episode Dermatophytosis: A Cross-Sectional Study. [PDF]
Agarwal S +6 more
europepmc +1 more source
Emergence of <i>Trichophyton indotineae: in vitro</i> susceptibility data from a mycology reference laboratory in Australia. [PDF]
Roudbary M +4 more
europepmc +1 more source
Teaching about dermatophytosis in the era of antifungal resistance: design, implementation, and evaluation of a multidisciplinary workshop in Honduras. [PDF]
Ortiz B +8 more
europepmc +1 more source
Clinical, Epidemiological, and Mycological Characteristics of Dermatophyte Infections: A Cross-Sectional Study From a Tertiary Care Hospital. [PDF]
Kowe P, Ghate S, Dhurat R.
europepmc +1 more source
A 38-year-old woman with tinea incognito. [PDF]
Jadhav A, Deo K, Singh V.
europepmc +1 more source
Dual therapy with minocycline and itraconazole as a new treatment option for recurrent dermatophytosis. [PDF]
Alhamdi DK, Abbas SF, AlHamdi KI.
europepmc +1 more source
Microsporum canis complex infections in the United Arab Emirates: Clinical, molecular, and antifungal susceptibility profiles. [PDF]
Anes F +12 more
europepmc +1 more source

